Predictive Oncology completes $343.5 million PIPE financing to support ATH token treasury strategy
According to ChainCatcher, citing Globenewswire, Nasdaq-listed company Predictive Oncology has announced the completion of a $343.5 million PIPE financing. The company will use these funds to purchase ATH tokens on the open market to support its ATH token treasury strategy.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Arthur Hayes responds to Monad co-founder: Unlock all tokens now and you will definitely succeed
Nasdaq executive: Tokenized stock plan is being actively advanced, with SEC approval listed as the top priority
dYdX community passes new proposal for "Liquidation Rebate Pilot Program"
Trending news
MoreCrypto prices
More
